Friday 6 November 2026 Export RMD’s income statement to Excel — free account

ResMed Inc.

RMD Healthcare Medical Instruments & Supplies

ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025.

Revenue: +5.93%
EPS: +23.1%
Free cash flow: −9.79%
Total debt: −38.9%

Quarter to September 2026, against a year earlier

233.21 6.10 −2.55%

Follow RMD

Alert me

Market cap: $33.7B
P/E: 21.7×
Fwd P/E: 19.6×
Dividend yield: 1.03%
F-score: 6/9
Altman Z: 10.00
Beneish M: −2.59
Dividend safety: 96/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
P/E ratio Full definition →	+8 more quarters Free account	23.73	21.58	18.63	20.08
P/S ratio Full definition →		6.51	5.89	5.02	5.51
P/FCF ratio Full definition →		19.77	18.79	17.41	19.90
P/Operating CF Full definition →		103.40	58.88	62.38	74.84
P/B ratio Full definition →		5.56	5.03	4.31	5.32
Price to Tangible BV Full definition →		12.34	10.79	8.80	12.17
EV/Sales Full definition →		6.32	5.66	4.83	5.38
EV/EBITDA Full definition →		16.52	14.55	12.81	14.48
EV/Operating CF Full definition →		17.82	16.60	15.11	17.42
EV/FCF Full definition →		19.20	18.07	16.76	19.42
Quick Ratio Full definition →		1.93	1.97	1.80	1.50
Current Ratio Full definition →		3.06	3.01	3.10	2.65
Net Debt/EBITDA Full definition →		(1.83)	(2.21)	(2.12)	(1.51)
Debt/Assets Full definition →		4.75%	4.60%	4.45%	3.04%
Debt/Equity Full definition →		0.06	0.06	0.06	0.04
Asset Turnover Full definition →		0.69	0.68	0.66	0.69
Operating CF/Net income Full definition →		0.87	1.39	1.19	1.01
Capex/Depreciation Full definition →		(0.55)	(0.57)	(1.04)	(0.99)
Interest Coverage Full definition →		(61.85)	(40.68)	(12.19)	94.10
Research and Development Expense of Revenue Full definition →		6.39%	6.59%	7.08%	7.27%
Selling, General and Administrative Expense of Revenue Full definition →		19.57%	19.96%	18.71%	22.24%
Intangible Assets out of Total Assets Full definition →		0.41	0.39	0.38	0.41
Share Based Compensation of Revenue Full definition →		2.03%	1.87%	1.88%	2.08%
Graham Net Nets Full definition →		0.05	0.05	0.07	0.04
Graham Number Full definition →		99.49	102.24	103.20	101.51
Earnings Yield Full definition →		4.21%	4.63%	5.37%	4.98%
Free Cash Flow Yield Full definition →		5.06%	5.32%	5.74%	5.02%
Revenue per Share Full definition →		9.76	9.85	10.06	9.89
Operating CF per Share Full definition →		2.33	3.81	3.12	2.95
Capex per Share Full definition →		(0.24)	(0.27)	(0.39)	(0.36)
Free Cash Flow per Share Full definition →		2.09	3.54	2.73	2.60
Cash per Share Full definition →		9.72	11.43	10.10	7.07
Shareholders Equity per Share Full definition →		43.34	44.67	45.25	41.60
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		43.34	44.67	45.25	41.60
Free Cash Flow Full definition →		305.19	514.54	397.38	371.25
Working Capital Full definition →		2,570.69	2,712.85	2,929.63	2,184.70
Capital Expenditures Full definition →		(34.55)	(39.59)	(57.25)	(51.17)
Net Current Asset Value Full definition →		1,636.31	1,771.69	1,944.18	1,244.80
EV/EBIT Full definition →		18.76	16.58	14.46	16.30
Capex to Sales Full definition →		0.02	0.03	0.04	0.04
Price to Operating Income Full definition →		19.31	17.24	15.03	16.70
Other line items
Average Receivables Full definition →		922.79	953.33	987.86	939.88
Average Payables Full definition →		235.36	247.93	293.54	293.73
Average Inventory Full definition →		902.07	887.26	936.76	983.58
Average Assets Full definition →		7,822.35	8,175.55	8,570.17	8,260.08
Average Common Equity Full definition →		5,786.94	6,019.02	6,276.63	6,034.48

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly